Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
40.04
-2.90 (-6.75%)
Oct 21, 2026, 3:55 PM HKT
Nanjing Leads Biolabs Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Morgan Stanley No rating | Morgan Stanley | Buy Upgrades $79.00 → $93.00 | Buy | Upgrades | $79.00 → $93.00 | +132.27% | Sep 16, 2026 |
Unknown Analyst Shenwan Hongyuan No rating | Shenwan Hongyuan | Buy Maintains $108.89 | Buy | Maintains | $108.89 | +171.95% | Sep 11, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $83.34 | Buy | Maintains | $83.34 | +108.14% | Sep 4, 2026 |
| CMB International Securities | CMB International Securities | Buy Reiterates $100.50 | Buy | Reiterates | $100.50 | +151.00% | Sep 3, 2026 |
Unknown Analyst CLSA No rating | CLSA | Buy Maintains $108.00 | Buy | Maintains | $108.00 | +169.73% | Jul 13, 2026 |
Unknown Analyst GF Securities No rating | GF Securities | Buy Maintains $110.96 | Buy | Maintains | $110.96 | +177.12% | Apr 28, 2026 |
Unknown Analyst Orient Securities No rating | Orient Securities | Buy Maintains $81.01 → $103.06 | Buy | Maintains | $81.01 → $103.06 | +157.39% | Apr 21, 2026 |